Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012
(in billion U.S. dollars)
Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
This statistic depicts the global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012. In that year, Swiss pharmaceutical company Novartis was ranked second based on prescription sales, generating some 45.4 billion U.S. dollars of revenue.

Top global pharmaceutical companies

Pfizer and Novartis are among the world’s largest pharmaceutical companies. Pfizer, headquartered in New York City, generated 47.4 billion U.S. dollars in prescription drug sales and spent 7.05 billion U.S. dollars on research and development in 2012. The pharmaceutical industry in the United States spent 40.1 billion U.S. dollars on R&D within the country and 10.97 billion U.S. dollars abroad in 2013. Globally, 137 billion U.S. dollars was spent on R&D in the pharmaceutical industry in 2013. As a whole, the pharmaceutical industry spends about 14.4 percent of their total revenues on R&D, in comparison to the 7.9 percent of technology hardware and equipment industries.

Europe and the United States have a strong influence on the market and are considered the leaders of this industry. North American industry sales reached 348.7 billion U.S. dollars in 2012. The global industry is expected to increase from 749 billion U.S. dollars in prescription drug revenues in 2014 to 1,017 billion U.S. dollars in 2020. Many companies spend a significant portion of their revenues in advertising of their products, often much more than they spend on R&D. Among the large pharmaceutical companies, there is an inherent pressure to increase sales which may create conflict between companies and public need.
Global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012
(in billion U.S. dollars)
Rx salesR&D spending
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
This statistic depicts the global top 50 pharmaceutical companies by prescription sales and R&D spending in 2012. In that year, Swiss pharmaceutical company Novartis was ranked second based on prescription sales, generating some 45.4 billion U.S. dollars of revenue.

Top global pharmaceutical companies

Pfizer and Novartis are among the world’s largest pharmaceutical companies. Pfizer, headquartered in New York City, generated 47.4 billion U.S. dollars in prescription drug sales and spent 7.05 billion U.S. dollars on research and development in 2012. The pharmaceutical industry in the United States spent 40.1 billion U.S. dollars on R&D within the country and 10.97 billion U.S. dollars abroad in 2013. Globally, 137 billion U.S. dollars was spent on R&D in the pharmaceutical industry in 2013. As a whole, the pharmaceutical industry spends about 14.4 percent of their total revenues on R&D, in comparison to the 7.9 percent of technology hardware and equipment industries.

Europe and the United States have a strong influence on the market and are considered the leaders of this industry. North American industry sales reached 348.7 billion U.S. dollars in 2012. The global industry is expected to increase from 749 billion U.S. dollars in prescription drug revenues in 2014 to 1,017 billion U.S. dollars in 2020. Many companies spend a significant portion of their revenues in advertising of their products, often much more than they spend on R&D. Among the large pharmaceutical companies, there is an inherent pressure to increase sales which may create conflict between companies and public need.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Novartis"
  • Global positioning
The most important statistics
  • Company overview
  • Revenue distribution
  • Research and development
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.